English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The aim was to evaluate the clinical utility of D-dimer POC assay analyzers to rule out the diagnosis of PTE in adult patients diagnosed with COVID-19. Systematic review and meta-analysis. The evaluated technology was the Point-of-Care D-dimer assay analyzer. To combine the effect estimates whose measure was the difference between the means, the random effect model was used. We included 10 studies that evaluated 14 Point-of-Care analyzers compared to the Enzyme Linked Immunosorbent Assay assay. All Point-of-Care analyzers evaluated showed sensitivity and NPV greater than 95 and 97%, respectively, with an average return time of 95 minutes. Evidence suggests that the use of Point-of-Care analyzers for D-dimer is clinically useful to rule out cases of pulmonary thromboembolism and other thromboembolic complications in patients with COVID-19 treated in the emergency room or in primary care units.

Utilidade clínica de analisadores de ensaio D- dímero Point-of-Care para exclusão de tromboembolismo pulmonar em pacientes com COVID-19